#begin document (bn/voa/00/voa_0023); part 000
bn/voa/00/voa_0023   0   0       01:45     CD  (TOP(NP*   -   -   -   -   (TIME*   -
bn/voa/00/voa_0023   0   1    Universal   NNP         *   -   -   -   -        *   -
bn/voa/00/voa_0023   0   2         Time   NNP         *   -   -   -   -        *   -
bn/voa/00/voa_0023   0   3            .     .        *))  -   -   -   -        *)  -

bn/voa/00/voa_0023   0   0    This    DT   (TOP(S(NP*)   -    -   -   -       *    (ARG1*)    -
bn/voa/00/voa_0023   0   1      is   VBZ         (VP*    be  01   2   -       *       (V*)    -
bn/voa/00/voa_0023   0   2     VOA   NNP      (NP(NP*    -    -   -   -   (ORG*    (ARG2*    (2)
bn/voa/00/voa_0023   0   3    News   NNP            *)   -    -   -   -       *)        *     -
bn/voa/00/voa_0023   0   4     now    RB     (ADVP*)))   -    -   -   -       *         *)    -
bn/voa/00/voa_0023   0   5       .     .           *))   -    -   -   -       *         *     -

bn/voa/00/voa_0023   0    0                A     DT      (TOP(S(NP(NP*              -    -   -   -   *        (ARG1*   (ARG0*         *        *        *         *            *    (5
bn/voa/00/voa_0023   0    1              new     JJ             (ADJP*              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0    2              and     CC                  *              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0    3           simple     JJ                  *)             -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0    4            blood     NN                  *              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0    5             test     NN                 *))             -    -   -   -   *             *)       *)        *        *        *         *            *     5)
bn/voa/00/voa_0023   0    6              may     MD               (VP*              -    -   -   -   *    (ARGM-MOD*)       *         *        *        *         *            *     -
bn/voa/00/voa_0023   0    7             soon     RB             (ADVP*)             -    -   -   -   *    (ARGM-TMP*)       *         *        *        *         *            *     -
bn/voa/00/voa_0023   0    8               be     VB               (VP*              be  01   1   -   *           (V*)       *         *        *        *         *            *     -
bn/voa/00/voa_0023   0    9        available     JJ             (ADJP*)             -    -   -   -   *        (ARG2*)       *         *        *        *         *            *     -
bn/voa/00/voa_0023   0   10               to     TO        (SBAR(S(VP*              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0   11             help     VB               (VP*            help  01   1   -   *             *      (V*)        *        *        *         *            *     -
bn/voa/00/voa_0023   0   12          doctors    NNS             (S(NP*)             -    -   -   -   *             *   (ARG1*    (ARG0*)       *        *         *            *    (6)
bn/voa/00/voa_0023   0   13             tell     VB               (VP*            tell  02   2   -   *             *        *       (V*)       *        *         *            *     -
bn/voa/00/voa_0023   0   14            which    WDT   (SBAR(WHNP(WHNP*)             -    -   -   -   *             *        *    (ARG1*   (ARG1*   (ARG1*         *            *     -
bn/voa/00/voa_0023   0   15               of     IN               (PP*              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0   16            their   PRP$               (NP*              -    -   -   -   *             *        *         *        *        *         *            *    (6)
bn/voa/00/voa_0023   0   17         diabetic     JJ                  *              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0   18         patients    NNS                *)))             -    -   -   -   *             *        *         *        *)       *)        *            *     -
bn/voa/00/voa_0023   0   19               is    VBZ             (S(VP*              be  01   1   -   *             *        *         *      (V*)       *         *            *     -
bn/voa/00/voa_0023   0   20             most    RBS             (ADJP*              -    -   -   -   *             *        *         *   (ARG2*        *         *            *     -
bn/voa/00/voa_0023   0   21           likely     JJ                  *              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0   22               to     TO             (S(VP*              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0   23          develop     VB               (VP*         develop  01   1   -   *             *        *         *        *      (V*)        *            *     -
bn/voa/00/voa_0023   0   24        crippling     JJ     (NP(ADJP(ADJP*)             -    -   -   -   *             *        *         *        *   (ARG2*         *   (ARGM-ADJ*     -
bn/voa/00/voa_0023   0   25              and     CC                  *              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0   26             life     NN             (ADJP*            life   -   3   -   *             *        *         *        *        *    (ARG2*)           *     -
bn/voa/00/voa_0023   0   27               -    HYPH                  *              -    -   -   -   *             *        *         *        *        *         *            *     -
bn/voa/00/voa_0023   0   28      threatening    VBG                 *))       threaten  01   -   -   *             *        *         *        *        *       (V*)           *)    -
bn/voa/00/voa_0023   0   29    complications    NNS   *))))))))))))))))   complication  01   3   -   *             *        *)        *)       *)       *)   (ARG0*)         (V*)    -
bn/voa/00/voa_0023   0   30                .      .                 *))             -    -   -   -   *             *        *         *        *        *         *            *     -

bn/voa/00/voa_0023   0   0         VOA   NNP  (TOP(S(NP(NP*         -    -   -   -       (ORG)  (ARG0*   (2
bn/voa/00/voa_0023   0   1          's   POS              *)        -    -   -   -          *        *    2)
bn/voa/00/voa_0023   0   2     Jessica   NNP              *         -    -   -   -   (PERSON*        *    -
bn/voa/00/voa_0023   0   3      Berman   NNP              *)        -    -   -   -          *)       *)   -
bn/voa/00/voa_0023   0   4    explains   VBZ           (VP*)   explain  01   1   -          *      (V*)   -
bn/voa/00/voa_0023   0   5           .     .             *))        -    -   -   -          *        *    -

bn/voa/00/voa_0023   0    0       Researcher    NN                  (TOP(S(NP*              -    -   -   -          *   (ARG0*      *      *             *         *      *   (10
bn/voa/00/voa_0023   0    1           Andrew   NNP                           *              -    -   -   -   (PERSON*        *      *      *             *         *      *     -
bn/voa/00/voa_0023   0    2             Levi   NNP                           *)             -    -   -   -          *)       *)     *      *             *         *      *    10)
bn/voa/00/voa_0023   0    3             says   VBZ                        (VP*             say  01   1   -          *      (V*)     *      *             *         *      *     -
bn/voa/00/voa_0023   0    4       scientists   NNS            (SBAR(SBAR(S(NP*)             -    -   -   -          *   (ARG1*      *      *        (ARG1*)        *      *     -
bn/voa/00/voa_0023   0    5             have   VBP                        (VP*            have  01   -   -          *        *    (V*)     *             *         *      *     -
bn/voa/00/voa_0023   0    6             long    RB                      (ADVP*)             -    -   -   -          *        *      *      *    (ARGM-TMP*)        *      *     -
bn/voa/00/voa_0023   0    7             been   VBN                        (VP*              be  03   -   -          *        *      *    (V*)            *         *      *     -
bn/voa/00/voa_0023   0    8          puzzled   VBN                        (VP*          puzzle  01   1   -          *        *      *      *           (V*)        *      *     -
bn/voa/00/voa_0023   0    9               by    IN                        (PP*              -    -   -   -          *        *      *      *        (ARG0*         *      *     -
bn/voa/00/voa_0023   0   10              the    DT                     (NP(NP*              -    -   -   -          *        *      *      *             *         *      *     -
bn/voa/00/voa_0023   0   11         question    NN                           *)       question   -   2   -          *        *      *      *             *         *      *     -
bn/voa/00/voa_0023   0   12               of    IN                        (PP*              -    -   -   -          *        *      *      *             *         *      *     -
bn/voa/00/voa_0023   0   13            which   WDT            (SBAR(SBAR(WHNP*              -    -   -   -          *        *      *      *             *    (ARG1*      *     -
bn/voa/00/voa_0023   0   14        diabetics   NNS                           *)             -    -   -   -          *        *      *      *             *         *)     *     -
bn/voa/00/voa_0023   0   15          develop   VBP                      (S(VP*         develop  01   1   -          *        *      *      *             *       (V*)     *     -
bn/voa/00/voa_0023   0   16    complications   NNS                     (NP*))))   complication  01   3   -          *        *      *      *             *    (ARG2*)   (V*)   (0)
bn/voa/00/voa_0023   0   17              and    CC                           *              -    -   -   -          *        *      *      *             *         *      *     -
bn/voa/00/voa_0023   0   18              why   WRB   (SBAR(WHADVP*)))))))))))))             -    -   -   -          *        *)     *      *             *)        *      *     -
bn/voa/00/voa_0023   0   19                .     .                          *))             -    -   -   -          *        *      *      *             *         *      *     -

bn/voa/00/voa_0023   0    0               We   PRP     (TOP(S(NP*)             -    -   -   -   *    (ARG0*)     *        *    -
bn/voa/00/voa_0023   0    1             know   VBP           (VP*            know  01   1   -   *       (V*)     *        *    -
bn/voa/00/voa_0023   0    2             that    IN         (SBAR*              -    -   -   -   *    (ARG1*      *        *    -
bn/voa/00/voa_0023   0    3              the    DT         (S(NP*              -    -   -   -   *         *      *   (ARG1*   (0
bn/voa/00/voa_0023   0    4    complications   NNS              *)   complication  01   3   -   *         *    (V*)       *)   0)
bn/voa/00/voa_0023   0    5              are   VBP           (VP*              be  01   1   -   *         *      *      (V*)   -
bn/voa/00/voa_0023   0    6         directly    RB         (ADJP*              -    -   -   -   *         *      *   (ARG2*    -
bn/voa/00/voa_0023   0    7          related    JJ              *              -    -   -   -   *         *      *        *    -
bn/voa/00/voa_0023   0    8               to    IN           (PP*              -    -   -   -   *         *      *        *    -
bn/voa/00/voa_0023   0    9                a    DT        (NP(NP*              -    -   -   -   *         *      *        *    -
bn/voa/00/voa_0023   0   10           couple    NN              *)         couple   -   1   -   *         *      *        *    -
bn/voa/00/voa_0023   0   11               of    IN           (PP*              -    -   -   -   *         *      *        *    -
bn/voa/00/voa_0023   0   12           things   NNS   (NP*)))))))))          thing   -   1   -   *         *)     *        *)   -
bn/voa/00/voa_0023   0   13                .     .             *))             -    -   -   -   *         *      *        *    -

bn/voa/00/voa_0023   0    0               One     CD        (TOP(S(S(NP*)             -    -    -   -    (CARDINAL)   (ARG1*)           *      *            *             *            *           *       -
bn/voa/00/voa_0023   0    1                is    VBZ                (VP*              be  01    1   -            *       (V*)           *      *            *             *            *           *       -
bn/voa/00/voa_0023   0    2               how    WRB  (SBAR(SBAR(WHADVP*              -    -    -   -            *    (ARG2*   (ARGM-TMP*      *            *             *            *           *       -
bn/voa/00/voa_0023   0    3              long     RB                   *)             -    -    -   -            *         *            *)     *            *             *            *           *       -
bn/voa/00/voa_0023   0    4               you    PRP              (S(NP*)             -    -    -   -            *         *       (ARG0*)     *            *             *            *           *       -
bn/voa/00/voa_0023   0    5               've    VBP                (VP*            have   -   12   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0    6               had    VBD                (VP*            have  03    2   -            *         *          (V*)     *            *             *            *           *       -
bn/voa/00/voa_0023   0    7               the     DT                (NP*              -    -    -   -            *         *       (ARG1*      *            *             *            *           *      (7
bn/voa/00/voa_0023   0    8          diabetes     NN               *)))))             -    -    -   -            *         *            *)     *            *             *            *           *       7)
bn/voa/00/voa_0023   0    9                 ,      ,                   *              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   10               how    WRB       (SBAR(WHADVP*              -    -    -   -            *         *            *      *   (ARGM-MNR*             *            *           *       -
bn/voa/00/voa_0023   0   11              well     RB                   *)             -    -    -   -            *         *            *      *            *)            *            *           *       -
bn/voa/00/voa_0023   0   12               you    PRP              (S(NP*)             -    -    -   -            *         *            *      *       (ARG1*)            *            *           *       -
bn/voa/00/voa_0023   0   13               've    VBP                (VP*            have   -   12   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   14              been    VBN                (VP*              be  03    -   -            *         *            *    (V*)           *             *            *           *       -
bn/voa/00/voa_0023   0   15        controlled    VBN         (VP*))))))))        control  01    1   -            *         *)           *      *          (V*)            *            *           *       -
bn/voa/00/voa_0023   0   16                 ,      ,                   *              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   17               but     CC                   *              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   18                it    PRP          (S(NP(NP*))             -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   19                's    VBZ                (VP*              be   -    1   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   20             clear     JJ              (ADJP*)             -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   21              that     IN              (SBAR*              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   22            people    NNS           (S(NP(NP*)         people   -    1   -            *         *            *      *            *        (ARG1*            *           *      (4
bn/voa/00/voa_0023   0   23              with     IN                (PP*              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   24               the     DT          (NP(NP(NP*              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   25              same     JJ                   *              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   26             level     NN                   *)          level   -    2   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   27                of     IN                (PP*              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   28           control     NN             (NP(NP*)        control   -    3   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   29                of     IN                (PP*              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   30             their   PRP$                (NP*              -    -    -   -            *         *            *      *            *             *            *           *      (4)
bn/voa/00/voa_0023   0   31           glucose     NN               *)))))             -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   32                 ,      ,                   *              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   33              same     JJ             (NP(NP*              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   34          duration     NN                   *)             -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   35                of     IN                (PP*              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   36               the     DT                (NP*              -    -    -   -            *         *            *      *            *             *            *           *      (7
bn/voa/00/voa_0023   0   37          diabetes     NN              *))))))             -    -    -   -            *         *            *      *            *             *)           *           *    7)|4)
bn/voa/00/voa_0023   0   38            differ    VBP                (VP*          differ  02    1   -            *         *            *      *            *           (V*)           *           *       -
bn/voa/00/voa_0023   0   39      dramatically     RB              (ADVP*)             -    -    -   -            *         *            *      *            *    (ARGM-MNR*)           *           *       -
bn/voa/00/voa_0023   0   40                in     IN                (PP*              -    -    -   -            *         *            *      *            *        (ARG2*            *           *       -
bn/voa/00/voa_0023   0   41             their   PRP$             (NP(NP*              -    -    -   -            *         *            *      *            *             *            *           *      (4)
bn/voa/00/voa_0023   0   42    susceptibility     NN                   *)             -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   43                to     IN                (PP*              -    -    -   -            *         *            *      *            *             *            *           *       -
bn/voa/00/voa_0023   0   44             these     DT             (NP(NP*              -    -    -   -            *         *            *      *            *             *            *      (ARG1*      (0
bn/voa/00/voa_0023   0   45     complications    NNS                   *)   complication  01    3   -            *         *            *      *            *             *          (V*)          *)      -
bn/voa/00/voa_0023   0   46              that    WDT         (SBAR(WHNP*)             -    -    -   -            *         *            *      *            *             *   (ARGM-ADJ*    (R-ARG1*)      -
bn/voa/00/voa_0023   0   47               are    VBP              (S(VP*              be  01    1   -            *         *            *      *            *             *            *         (V*)      -
bn/voa/00/voa_0023   0   48                so     RB              (ADJP*              -    -    -   -            *         *            *      *            *             *            *      (ARG2*       -
bn/voa/00/voa_0023   0   49       devastating     JJ       *)))))))))))))             -    -    -   -            *         *            *      *            *             *)           *)          *)      0)
bn/voa/00/voa_0023   0   50                 .      .                  *))             -    -    -   -            *         *            *      *            *             *            *           *       -

bn/voa/00/voa_0023   0    0         Dr.   NNP        (TOP(S(NP*         -    -    -   -            *   (ARG0*         *        *        *        *   (10
bn/voa/00/voa_0023   0    1        Levi   NNP                 *)        -    -    -   -      (PERSON)       *)        *        *        *        *    10)
bn/voa/00/voa_0023   0    2        says   VBZ              (VP*        say  01    1   -            *      (V*)        *        *        *        *     -
bn/voa/00/voa_0023   0    3         one    CD  (SBAR(S(S(NP(NP*         -    -    -   -   (CARDINAL*   (ARG1*         *   (ARG1*        *        *     -
bn/voa/00/voa_0023   0    4       third    NN                 *)        -    -    -   -            *)       *         *        *        *        *     -
bn/voa/00/voa_0023   0    5          of    IN              (PP*         -    -    -   -            *        *         *        *        *        *     -
bn/voa/00/voa_0023   0    6     insulin    NN         (NP(ADJP*         -    -    -   -            *        *    (ARG1*)       *        *        *     -
bn/voa/00/voa_0023   0    7      taking   VBG                 *)      take  01   12   -            *        *       (V*)       *        *        *     -
bn/voa/00/voa_0023   0    8    patients   NNS               *)))        -    -    -   -            *        *    (ARG0*)       *)       *        *     -
bn/voa/00/voa_0023   0    9        ends   VBZ              (VP*        end  03    4   -            *        *         *      (V*)       *        *     -
bn/voa/00/voa_0023   0   10          up    RP             (PRT*)        -    -    -   -            *        *         *        *        *        *     -
bn/voa/00/voa_0023   0   11        with    IN              (PP*         -    -    -   -            *        *         *   (ARG2*        *        *     -
bn/voa/00/voa_0023   0   12      kidney    NN              (NP*         -    -    -   -            *        *         *        *        *        *     -
bn/voa/00/voa_0023   0   13     failure    NN              *))))        -    -    -   -            *        *         *        *)       *        *     -
bn/voa/00/voa_0023   0   14         and    CC                 *         -    -    -   -            *        *         *        *        *        *     -
bn/voa/00/voa_0023   0   15         80     CD            (S(NP*         -    -    -   -    (PERCENT*        *         *        *   (ARG1*        *     -
bn/voa/00/voa_0023   0   16           %    NN                 *)        -    -    -   -            *)       *         *        *        *)       *     -
bn/voa/00/voa_0023   0   17     develop   VBP              (VP*    develop  01    1   -            *        *         *        *      (V*)       *     -
bn/voa/00/voa_0023   0   18    blinding   VBG              (NP*      blind  01    -   -            *        *         *        *   (ARG2*      (V*)    -
bn/voa/00/voa_0023   0   19         eye    NN                 *        eye   -    1   -            *        *         *        *        *   (ARG0*     -
bn/voa/00/voa_0023   0   20     disease    NN            *))))))        -    -    -   -            *        *)        *        *        *)       *)    -
bn/voa/00/voa_0023   0   21           .     .                *))        -    -    -   -            *        *         *        *        *        *     -

bn/voa/00/voa_0023   0    0       Scientists    NNS          (TOP(S(S(NP*)             -    -    -   -   *      *    (ARG0*)            *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0    1             have    VBP                  (VP*            have  01    -   -   *    (V*)        *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0    2        suspected    VBN                  (VP*         suspect  01    1   -   *      *       (V*)            *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0    3            there     EX           (SBAR(S(NP*)             -    -    -   -   *      *    (ARG1*             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0    4             must     MD                  (VP*              -    -    -   -   *      *         *    (ARGM-MOD*)     *             *           *          *        *        *    -
bn/voa/00/voa_0023   0    5               be     VB                  (VP*              be  02    1   -   *      *         *           (V*)     *             *           *          *        *        *    -
bn/voa/00/voa_0023   0    6        something     NN               (NP(NP*)      something   -    2   -   *      *         *        (ARG1*      *             *           *          *        *        *   (3
bn/voa/00/voa_0023   0    7        different     JJ                (ADJP*)             -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0    8            about     IN                  (PP*              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0    9              the     DT               (NP(NP*              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   10          genetic     JJ                     *              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   11             make     NN                     *              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   12               -    HYPH                     *              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   13               up     NN                     *)             -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   14               of     IN                  (PP*              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   15        diabetics    NNS               (NP(NP*)             -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   16              who     WP           (SBAR(WHNP*)             -    -    -   -   *      *         *             *      *             *    (R-ARG0*)         *        *        *    -
bn/voa/00/voa_0023   0   17          develop    VBP                (S(VP*         develop   -    1   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   18    complications    NNS   (NP*))))))))))))))))   complication  01    3   -   *      *         *)            *)   (V*)            *           *          *        *        *    3)
bn/voa/00/voa_0023   0   19                ;      :                     *              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   20              and     CC                     *              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   21             that     DT                (S(NP*              -    -    -   -   *      *         *             *      *             *      (ARG0*          *        *        *   (3
bn/voa/00/voa_0023   0   22       difference     NN                     *)     difference   -    1   -   *      *         *             *      *             *           *)         *        *        *    3)
bn/voa/00/voa_0023   0   23              may     MD                  (VP*              -    -    -   -   *      *         *             *      *    (ARGM-MOD*)          *          *        *        *    -
bn/voa/00/voa_0023   0   24             have     VB                  (VP*            have  02   12   -   *      *         *             *      *           (V*)          *          *        *        *    -
bn/voa/00/voa_0023   0   25               to     TO                (S(VP*              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   26               do     VB                  (VP*              do  04    1   -   *      *         *             *      *             *         (V*)         *        *        *    -
bn/voa/00/voa_0023   0   27             with     IN                  (PP*              -    -    -   -   *      *         *             *      *             *      (ARG1*          *        *        *    -
bn/voa/00/voa_0023   0   28      haptoglobin     NN               (NP(NP*)             -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   29                ,      ,                     *              -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   30                a     DT               (NP(NP*              -    -    -   -   *      *         *             *      *             *           *     (ARG1*        *        *    -
bn/voa/00/voa_0023   0   31          protein     NN                     *)             -    -    -   -   *      *         *             *      *             *           *          *)       *        *    -
bn/voa/00/voa_0023   0   32            whose    WP$           (SBAR(WHNP*              -    -    -   -   *      *         *             *      *             *           *   (R-ARG1*        *        *    -
bn/voa/00/voa_0023   0   33         function     NN                     *)       function   -    3   -   *      *         *             *      *             *           *          *)       *        *    -
bn/voa/00/voa_0023   0   34               is    VBZ                (S(VP*              be  01    1   -   *      *         *             *      *             *           *        (V*)       *        *    -
bn/voa/00/voa_0023   0   35               to     TO                (S(VP*              -    -    -   -   *      *         *             *      *             *           *     (ARG2*        *        *    -
bn/voa/00/voa_0023   0   36              mop     VB                  (VP*             mop  01    -   -   *      *         *             *      *             *           *          *      (V*)       *    -
bn/voa/00/voa_0023   0   37               up     RP                 (PRT*)             -    -    -   -   *      *         *             *      *             *           *          *        *        *    -
bn/voa/00/voa_0023   0   38            blood     NN         (NP(ADJP(NML*              -    -    -   -   *      *         *             *      *             *           *          *   (ARG1*   (ARG1*   (9
bn/voa/00/voa_0023   0   39           vessel     NN                     *)             -    -    -   -   *      *         *             *      *             *           *          *        *        *)   -
bn/voa/00/voa_0023   0   40       destroying    VBG                     *)        destroy  01    -   -   *      *         *             *      *             *           *          *        *      (V*)   -
bn/voa/00/voa_0023   0   41             free     JJ                     *              -    -    -   -   *      *         *             *      *             *           *          *        *   (ARG0*    -
bn/voa/00/voa_0023   0   42         radicals    NNS      *))))))))))))))))             -    -    -   -   *      *         *             *      *             *           *)         *)       *)       *)   9)
bn/voa/00/voa_0023   0   43                .      .                    *))             -    -    -   -   *      *         *             *      *             *           *          *        *        *    -

bn/voa/00/voa_0023   0    0            The    DT      (TOP(S(NP*         -    -   -   -   *      *       (ARG1*         *         *             *   (9
bn/voa/00/voa_0023   0    1           free    JJ               *         -    -   -   -   *      *            *         *         *             *    -
bn/voa/00/voa_0023   0    2       radicals   NNS               *)        -    -   -   -   *      *            *)        *         *             *    9)
bn/voa/00/voa_0023   0    3            are   VBP            (VP*         be  03   -   -   *    (V*)           *         *         *             *    -
bn/voa/00/voa_0023   0    4       released   VBN            (VP*    release  01   3   -   *      *          (V*)        *         *             *    -
bn/voa/00/voa_0023   0    5           when   WRB   (SBAR(WHADVP*)        -    -   -   -   *      *   (ARGM-TMP*         *         *    (ARGM-TMP*)   -
bn/voa/00/voa_0023   0    6         oxygen    NN  (S(NP(NP(ADJP*         -    -   -   -   *      *            *    (ARG1*)   (ARG1*        (ARG1*    -
bn/voa/00/voa_0023   0    7       carrying   VBG               *)     carry  01   -   -   *      *            *       (V*)        *             *    -
bn/voa/00/voa_0023   0    8            red    JJ               *         -    -   -   -   *      *            *    (ARG0*         *             *    -
bn/voa/00/voa_0023   0    9          blood    NN               *         -    -   -   -   *      *            *         *         *             *    -
bn/voa/00/voa_0023   0   10          cells   NNS               *)      cell   -   1   -   *      *            *         *)        *)            *    -
bn/voa/00/voa_0023   0   11         called   VBN            (VP*       call  01   5   -   *      *            *         *       (V*)            *    -
bn/voa/00/voa_0023   0   12    haemoglobin    NN       (S(NP*))))        -    -   -   -   *      *            *         *    (ARG2*)            *)   -
bn/voa/00/voa_0023   0   13            die   VBP        (VP*)))))       die  01   1   -   *      *            *)        *         *           (V*)   -
bn/voa/00/voa_0023   0   14              .     .              *))        -    -   -   -   *      *            *         *         *             *    -

bn/voa/00/voa_0023   0    0           Andrew    NNP      (TOP(S(NP*              -    -   -   -     (PERSON*   (ARG0*        *      *        *        *            *         *      *       (10
bn/voa/00/voa_0023   0    1             Levi    NNP               *)             -    -   -   -            *)       *)       *      *        *        *            *         *      *        10)
bn/voa/00/voa_0023   0    2             says    VBZ            (VP*             say  01   1   -            *      (V*)       *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0    3            there     EX   (SBAR(S(S(NP*)             -    -   -   -            *   (ARG1*        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0    4              are    VBP            (VP*              be  02   3   -            *        *      (V*)     *        *        *            *         *      *         -
bn/voa/00/voa_0023   0    5            three     CD         (NP(NP*              -    -   -   -    (CARDINAL)       *   (ARG1*      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0    6        different     JJ               *              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0    7            types    NNS               *)           type   -   1   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0    8               of     IN            (PP*              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0    9      haptoglobin     NN        (NP*)))))             -    -   -   -            *        *        *)     *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   10              and     CC               *              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   11               he    PRP       (S(NP(NP*)             -    -   -   -            *        *        *      *   (ARG0*        *            *         *      *    (1|(10)
bn/voa/00/voa_0023   0   12              and     CC               *              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   13              his   PRP$         (NP(NP*              -    -   -   -            *        *        *      *        *        *            *         *      *       (10)
bn/voa/00/voa_0023   0   14       colleagues    NNS               *)             -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   15               at     IN            (PP*              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   16           Israel    NNP         (NP(NP*              -    -   -   -         (GPE)       *        *      *        *        *            *         *      *        (8
bn/voa/00/voa_0023   0   17               's    POS               *)             -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   18         Technion    NNP               *              -    -   -   -        (ORG*        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   19        Institute    NNP            *))))             -    -   -   -            *)       *        *      *        *)       *            *         *      *      8)|1)
bn/voa/00/voa_0023   0   20             have    VBP            (VP*            have  01   -   -            *        *        *    (V*)       *        *            *         *      *         -
bn/voa/00/voa_0023   0   21            found    VBN            (VP*            find  01   1   -            *        *        *      *      (V*)       *            *         *      *         -
bn/voa/00/voa_0023   0   22             that     IN          (SBAR*              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   23              one     CD       (S(NP(NP*              -    -   -   -    (CARDINAL)       *        *      *   (ARG1*        *       (ARG1*         *      *         -
bn/voa/00/voa_0023   0   24             type     NN               *)           type   -   1   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   25               of     IN            (PP*              -    -   -   -            *        *        *      *        *   (ARG1*            *         *      *         -
bn/voa/00/voa_0023   0   26      haptoglobin     NN           (NP*))             -    -   -   -            *        *        *      *        *        *)           *         *      *         -
bn/voa/00/voa_0023   0   27           called    VBN            (VP*            call  01   5   -            *        *        *      *        *      (V*)           *         *      *         -
bn/voa/00/voa_0023   0   28             Type    NNP          (S(NP*              -    -   -   -            *        *        *      *        *   (ARG2*            *         *      *         -
bn/voa/00/voa_0023   0   29               1     NNP               *              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   30               -    HYPH               *              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   31               1     NNP            *))))             -    -   -   -            *        *        *      *        *        *)           *)        *      *         -
bn/voa/00/voa_0023   0   32          appears    VBZ            (VP*          appear  02   1   -            *        *        *      *        *        *          (V*)        *      *         -
bn/voa/00/voa_0023   0   33       protective     JJ        (S(ADJP*              -    -   -   -            *        *        *      *        *        *     (C-ARG1*         *      *         -
bn/voa/00/voa_0023   0   34          against     IN            (PP*              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   35         diabetic     JJ            (NP*              -    -   -   -            *        *        *      *        *        *            *    (ARG0*)     *         -
bn/voa/00/voa_0023   0   36    complications    NNS            *))))   complication  01   3   -            *        *        *      *        *        *            *)      (V*)     *         -
bn/voa/00/voa_0023   0   37            while     IN          (SBAR*              -    -   -   -            *        *        *      *        *        *   (ARGM-ADV*         *      *         -
bn/voa/00/voa_0023   0   38              the     DT          (S(NP*              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   39            other     JJ               *              -    -   -   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   40              two     CD               *              -    -   -   -    (CARDINAL)       *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   41            types    NNS               *)           type   -   1   -            *        *        *      *        *        *            *         *      *         -
bn/voa/00/voa_0023   0   42               do    VBP            (VP*              do  01   1   -            *        *        *      *        *        *            *         *    (V*)        -
bn/voa/00/voa_0023   0   43              not     RB    *))))))))))))             -    -   -   -            *        *)       *      *        *)       *            *)        *      *         -
bn/voa/00/voa_0023   0   44                .      .              *))             -    -   -   -            *        *        *      *        *        *            *         *      *         -

bn/voa/00/voa_0023   0    0      Researchers   NNS    (TOP(S(NP(NP(NP*)             -    -   -   -          *   (ARG1*      *   (ARG0*        *        *         *         *         *       (1
bn/voa/00/voa_0023   0    1               at    IN                (PP*              -    -   -   -          *        *      *        *        *        *         *         *         *        -
bn/voa/00/voa_0023   0    2         Technion   NNP                (NP*              -    -   -   -      (ORG*        *      *        *        *        *         *         *         *       (8
bn/voa/00/voa_0023   0    3        Institute   NNP                 *)))             -    -   -   -          *)       *)     *        *        *        *         *         *         *        8)
bn/voa/00/voa_0023   0    4              led   VBN                (VP*            lead  02   4   -          *      (V*)     *        *        *        *         *         *         *        -
bn/voa/00/voa_0023   0    5               by    IN                (PP*              -    -   -   -          *   (ARG0*      *        *        *        *         *         *         *        -
bn/voa/00/voa_0023   0    6              Dr.   NNP                (NP*              -    -   -   -          *        *      *        *        *        *         *         *         *      (10
bn/voa/00/voa_0023   0    7             Levi   NNP                *))))             -    -   -   -    (PERSON)       *)     *        *)       *        *         *         *         *    10)|1)
bn/voa/00/voa_0023   0    8             have   VBP                (VP*            have  01   -   -          *        *    (V*)       *        *        *         *         *         *        -
bn/voa/00/voa_0023   0    9        developed   VBN                (VP*         develop  02   1   -          *        *      *      (V*)       *        *         *         *         *        -
bn/voa/00/voa_0023   0   10                a    DT             (NP(NP*              -    -   -   -          *        *      *   (ARG1*   (ARG0*        *         *         *         *       (5
bn/voa/00/voa_0023   0   11           simple    JJ                   *              -    -   -   -          *        *      *        *        *        *         *         *         *        -
bn/voa/00/voa_0023   0   12            blood    NN                   *              -    -   -   -          *        *      *        *        *        *         *         *         *        -
bn/voa/00/voa_0023   0   13             test    NN                   *)             -    -   -   -          *        *      *        *        *)       *         *         *         *        -
bn/voa/00/voa_0023   0   14               to    TO         (SBAR(S(VP*              -    -   -   -          *        *      *        *        *        *         *         *         *        -
bn/voa/00/voa_0023   0   15              let    VB                (VP*             let  01   1   -          *        *      *        *      (V*)       *         *         *         *        -
bn/voa/00/voa_0023   0   16          doctors   NNS              (S(NP*              -    -   -   -          *        *      *        *   (ARG1*   (ARG0*         *         *         *        -
bn/voa/00/voa_0023   0   17              and    CC                   *              -    -   -   -          *        *      *        *        *        *         *         *         *        -
bn/voa/00/voa_0023   0   18         patients   NNS                   *)             -    -   -   -          *        *      *        *        *        *)        *         *         *        -
bn/voa/00/voa_0023   0   19             know    VB                (VP*            know  01   1   -          *        *      *        *        *      (V*)        *         *         *        -
bn/voa/00/voa_0023   0   20              who    WP         (SBAR(WHNP*)             -    -   -   -          *        *      *        *        *   (ARG1*    (ARG1*)   (ARG1*)        *        -
bn/voa/00/voa_0023   0   21               is   VBZ              (S(VP*              be  01   1   -          *        *      *        *        *        *       (V*)        *         *        -
bn/voa/00/voa_0023   0   22             most   RBS              (ADJP*              -    -   -   -          *        *      *        *        *        *    (ARG2*         *         *        -
bn/voa/00/voa_0023   0   23           likely    JJ                   *              -    -   -   -          *        *      *        *        *        *         *         *         *        -
bn/voa/00/voa_0023   0   24               to    TO              (S(VP*              -    -   -   -          *        *      *        *        *        *         *         *         *        -
bn/voa/00/voa_0023   0   25          develop    VB                (VP*         develop  01   1   -          *        *      *        *        *        *         *       (V*)        *        -
bn/voa/00/voa_0023   0   26         diabetic    JJ                (NP*              -    -   -   -          *        *      *        *        *        *         *    (ARG2*    (ARG0*)       -
bn/voa/00/voa_0023   0   27    complications   NNS   *)))))))))))))))))   complication  01   3   -          *        *      *        *)       *)       *)        *)        *)      (V*)       5)
bn/voa/00/voa_0023   0   28                .     .                  *))             -    -   -   -          *        *      *        *        *        *         *         *         *        -

#end document
